Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents

International Journal of Obesity

Volumn 40, Issue 6, 2016, Pages 1026-1033

  Rainone, V ^a   Schneider, L ^a   Saulle, I ^a   Ricci, C ^b   Biasin, M ^a   Al Daghri, N M ^c,d   Giani, E ^e   Zuccotti, G V ^a,e   Clerici, M ^e,f   Trabattoni, D ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e UNIVERSITY OF MILAN   (Italy)

^f IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CASPASE 5; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD14 ANTIGEN; CRYOPYRIN; FATTY ACID BINDING PROTEIN 2; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN; PROTEIN BIRC2; PROTEIN NLRX1; PROTEIN P2RX7; PROTEIN RIPK2; PROTEIN TIRAP; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARRIER PROTEIN;

ADOLESCENT; ADOLESCENT OBESITY; ANTHROPOMETRY; ARTICLE; BACTERIAL TRANSLOCATION; BEHAVIOR THERAPY; CHILD; CHILDHOOD OBESITY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; UPREGULATION; ADIPOGENESIS; CARDIOVASCULAR DISEASE; FEMALE; GENE EXPRESSION REGULATION; INTESTINE ABSORPTION; INTESTINE MUCOSA; INTRA-ABDOMINAL FAT; ITALY; MACROPHAGE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ADIPOGENESIS; ADOLESCENT; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMASOMES; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTRA-ABDOMINAL FAT; ITALY; LONGITUDINAL STUDIES; MACROPHAGES; MALE; PEDIATRIC OBESITY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84961393640     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2016.26     Document Type: Article

References (46)

1. WHO. Obesity and Overweight. Fact Sheet NO 311. WHO: Geneva, Switzerland. 2012.
2. De Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. AM J Clin Nutr 2010; 92: 1257-1264.
3. Ogden CL, Carrol MD, Kit BK. Prevalence of childhood and adult obesity in the United States, 2011-2012. J Am Med Assn 2014; 311: 806-814.
4. Bleich S, Cutler D, Murray C, Adams A. Why is the developed world obese? Annu Rev Public Health 2008; 29: 273-295.
5. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337: 869-873.
6. Allison DB, Fontaine KR, Manson JE, Stevens J, VaItallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999; 282: 1530-1538.
7. Peirson L, Fitzpatrick-Lewis D, Morrison K, Warren R, Usman Ali M, Raina P. Treatment of overweight and obesity in children and youth: A systematic review and meta-analysis. CMAJ Open 2015; 3: E35-E46.
8. Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I. Dietary gut microbial metabolites, short-chain fatty acids and host metabolic regulation. Nutrients 2015; 7: 2839-2849.
9. Zhang YJ, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impact of gut bacteria on human health and diseases. Int J Mol Sci 2015; 16: 7493-7519.
10. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Prac Res Clin Gastr 2013; 27: 73-83.
11. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445.
12. Haneklaus M, O'Neill LA. NLRP3 at the interface of metabolism and inflammation. Immunol Rev 2015; 265: 53-62.
13. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity 2014; 41: 36-48.
14. Odegaard JI, Chawla A. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab 2008; 4: 619-622.
15. Olefsky JM, Glass CK. Macrophage, inflammation, ad insulin resistance. Annu Rev Physiol 2010; 72: 219-246.
16. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Naver A et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells That affects metabolic parameters. Nat Med 2009; 15: 930-939.
17. Snyder-Cappione JE, Nikolajczyk BS. When diet and exercise are not enough, think immunomodulation. Mol Asp Of Med 2013; 34: 30-38.
18. Harrington DM, Staiano AE, Broyles ST, Gupta AK, Katzmarzyk PT. BMI percentiles for the identification of abdominal obesity and metabolic risk in children and adolescents: evidence in support of the CDC 95°C percentile. Eur J Clin Nutr 2013; 67: 218-222.
19. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L et al. Italian crosssectional growth charts for height, weight and BMI ( 2 to 20 yr). J Endocrinol Invest 2006; 29: 581-593.
20. Edmunds L, Waters E, Elliott EJ. Evidence based management of childhood obesity. BMJ 2001; 323: 916-919.
21. National High Blood Pressure Education Program Working Group. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatric 2004; 114: 555-576.
22. Lohman TG, Roche AF, Martorell R. Anthropometrical Standardization Reference Manual Edited byLohman TG, Roche AF, Martorell R) (Human Kinetics Books': Champaign, IL, USA, 1988.
23. McCarthy HD, Jarrett KV, Crawley HF. The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J Clin Nutr 2001; 55: 902-907.
24. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128(Suppl 5): S213-S256.
25. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol 1994; 13: 373-383.
26. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990; 264: 2519-2523.
27. Spear BA, Barlow SE, Ervin C, Ludwig DS, Saelens BE, Schetzina KE et al. Recommendations for treatment of child and adolescent overweight and obesity. Pediatrics 2007; 120 (Suppl 4): S254-S288.
28. Strasburger VC. American Academy of Pediatrics. Council on communications and media. Policy statement-children, adolescents, substance abuse, and the media. Pediatrics 2010; 126: 791-799.
29. Waters E, de Silva-Sanigorski A, Hall BJ, Brown T, Campbell KJ, Gao Y et al. Interventions for preventing obesity in children. Cochrane Database Syst Rev 2011; 12: CD001871.
30. American Academy of Pediatrics. Physical fitness and activity in schools. Pediatrics 2000; 105: 1156-1157.
31. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761-811.
32. Fonvig CE, Bille DS, Chabanova E, Nielsen TR, Thomsen HS, Holm JC. Muscle fat content and abdominal adipose tissue distribution investigated by magnetic resonance spectroscopy and imaging in obese children and youths. Pediatr Rep 2012; 4: e11.
33. Pedersen BK. Muscles and their myokines. J Exp Biol 2011; 214: 337-346.
34. I'Allemand D, Wiegand S, Reinehr T, Muller J, Wabitsch M, Widhalm K et al. Cardiovascular risk in 2008 European overweight children as established by a multicenter database. Obesity 2008; 16: 1672-1679.
35. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 2012; 7: 284-294.
36. Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H et al. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab 2011; 96: E146-E150.
37. Levitan EB, Cook NR, Stampfer MJ, Ridker PM, Rexrode KM, Buring JE et al. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism 2008; 57: 437-443.
38. Qi L, Rimm E, Liu S, Rifai N, Hu FB. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 2005; 28: 1022-1028.
39. Pedersen BK, Fischer CP. Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends Pharmacol Sci 2007; 28: 152-156.
40. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-1162.
41. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89-102.
42. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007; 27: 98-114.
43. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994; 8: 1314-1325.
44. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-474.
45. Fowler BJ, Gelfand BD, Kim Y, Kerur N, Tarallo V, Hirano Y et al. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science 2014; 346: 1000-1003.
46. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34(Suppl 1): S11-S61.